Effects of Treatment with sodium/glucose cotransporter 2 inhibitor on Diabetic Nephropathy.
Hidehisa Sasaki 1), Yuma Tamai2), Kento Hamajima2), Chika Tahara1), Madoka Nakamura1), Masaru Mizoguchi1), Go Miura1), Hiroyuki Nagasawa2)
The present results suggest that SGLT2 inhibitors suppress the progression of diabetic nephropathy regardless of the severity of renal function.
日本予防医学会雑誌
Vol.17
NO.1